Stage II Mycosis Fungoides and Sezary Syndrome AJCC v8
3 clinical trials · Condition
◉ Watch Stage II Mycosis Fungoides and Sezary Syndrome AJCC v8
| Record | Firm | Date |
|---|---|---|
| Extracorporeal Photopheresis and Mogamulizumab for the Treatment of Erythrodermic Cutaneous T Cell Lymphoma (NCT04930653) | City of Hope Medical Center | 2022-10-19 |
| Testing the Addition of an Anti-cancer Drug, Hu5F9-G4 (Magrolimab), to the Usual Chemotherapy Treatment (Mogamulizumab) in T-Cell (a Type of Immune Cell) Lymphoma That Has Returned After Treatment or Does Not Respond to Treatment (NCT04541017) | National Cancer Institute (NCI) | 2021-04-06 |
| Pembrolizumab in Treating Patients With Stage IB-IV Mycosis Fungoides (NCT03695471) | Mayo Clinic | 2020-02-04 |
Track Stage II Mycosis Fungoides and Sezary Syndrome AJCC v8 automatically
Every clearance here is in the API, with alerts when new ones post.